This site is intended for US audiences only.

Skip to content

Main Navigation

For Patients
For Healthcare Professionals
Resources

The University of Texas MD Anderson Cancer Center

Posted on April 3, 2024 (June 11, 2024) by lum-dev

Houston, TX 77030

Post navigation

Oncology Consultants Texas Medical CenterFroedtert & Medical College of Wisconsin

Ficlatuzumab is an investigational drug and has not yet been approved by the US Food and Drug Administration (FDA).

Footer Navigation

Terms of Use
Privacy Policy
Cookie Policy
Contact Us

© 2024 AVEO Pharmaceuticals, Inc. All rights reserved. US-MAT-00305 4/24